These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 10716682)

  • 41. Long-term efficacy of polyethylene glycol 3350 for the treatment of chronic constipation in children with and without encopresis.
    Pashankar DS; Bishop WP; Loening-Baucke V
    Clin Pediatr (Phila); 2003; 42(9):815-9. PubMed ID: 14686553
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tolerance and Long-Term Efficacy of Polyethylene Glycol 4000 (Forlax®) Compared to Lactulose in Elderly Patients with Chronic Constipation.
    Chassagne P; Ducrotte P; Garnier P; Mathiex-Fortunet H
    J Nutr Health Aging; 2017; 21(4):429-439. PubMed ID: 28346570
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of tegaserod in chronic constipation: a randomized, double-blind, controlled trial.
    Johanson JF; Wald A; Tougas G; Chey WD; Novick JS; Lembo AJ; Fordham F; Guella M; Nault B
    Clin Gastroenterol Hepatol; 2004 Sep; 2(9):796-805. PubMed ID: 15354280
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives.
    Tack J; van Outryve M; Beyens G; Kerstens R; Vandeplassche L
    Gut; 2009 Mar; 58(3):357-65. PubMed ID: 18987031
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Systematic review and meta analysis: polyethylene glycol in adults with non-organic constipation.
    Belsey JD; Geraint M; Dixon TA
    Int J Clin Pract; 2010 Jun; 64(7):944-55. PubMed ID: 20584228
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A randomised, double-blind study of polyethylene glycol 4000 and lactulose in the treatment of constipation in children.
    Treepongkaruna S; Simakachorn N; Pienvichit P; Varavithya W; Tongpenyai Y; Garnier P; Mathiex-Fortunet H
    BMC Pediatr; 2014 Jun; 14():153. PubMed ID: 24943105
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of efficacy and safety of two doses of two different polyethylene glycol-based laxatives in the treatment of constipation.
    Chaussade S; Minić M
    Aliment Pharmacol Ther; 2003 Jan; 17(1):165-72. PubMed ID: 12492746
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety.
    Chey WD; Lembo AJ; Lavins BJ; Shiff SJ; Kurtz CB; Currie MG; MacDougall JE; Jia XD; Shao JZ; Fitch DA; Baird MJ; Schneier HA; Johnston JM
    Am J Gastroenterol; 2012 Nov; 107(11):1702-12. PubMed ID: 22986437
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A placebo-controlled trial of prucalopride for severe chronic constipation.
    Camilleri M; Kerstens R; Rykx A; Vandeplassche L
    N Engl J Med; 2008 May; 358(22):2344-54. PubMed ID: 18509121
    [TBL] [Abstract][Full Text] [Related]  

  • 50. PEG 3350 Versus Lactulose for Treatment of Functional Constipation in Children: Randomized Study.
    Jarzebicka D; Sieczkowska-Golub J; Kierkus J; Czubkowski P; Kowalczuk-Kryston M; Pelc M; Lebensztejn D; Korczowski B; Socha P; Oracz G
    J Pediatr Gastroenterol Nutr; 2019 Mar; 68(3):318-324. PubMed ID: 30383579
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lack of lasting effectiveness of PEG 3350 laxative treatment of constipation.
    Tran LC; Di Palma JA
    J Clin Gastroenterol; 2005 Aug; 39(7):600-2. PubMed ID: 16000928
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Comparison of the effectiveness and safety of polyethylene glycol with and without electrolytes in the treatment of chronic constipation].
    Llerena E; Varea Calderón V; Pujol Muncunill G; Hernandez Hernandez K; Sosa Giraldo FJ; Suarez Fuentes T; Martín de Carpi J
    An Pediatr (Barc); 2016 Jul; 85(1):34-40. PubMed ID: 26601572
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
    Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
    Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy and optimal dose of daily polyethylene glycol 3350 for treatment of constipation and encopresis in children.
    Pashankar DS; Bishop WP
    J Pediatr; 2001 Sep; 139(3):428-32. PubMed ID: 11562624
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy of linaclotide for patients with chronic constipation.
    Lembo AJ; Kurtz CB; Macdougall JE; Lavins BJ; Currie MG; Fitch DA; Jeglinski BI; Johnston JM
    Gastroenterology; 2010 Mar; 138(3):886-95.e1. PubMed ID: 20045700
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of chronic constipation with cisapride and placebo.
    Müller-Lissner SA
    Gut; 1987 Aug; 28(8):1033-8. PubMed ID: 3311905
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rectal fecal impaction treatment in childhood constipation: enemas versus high doses oral PEG.
    Bekkali NL; van den Berg MM; Dijkgraaf MG; van Wijk MP; Bongers ME; Liem O; Benninga MA
    Pediatrics; 2009 Dec; 124(6):e1108-15. PubMed ID: 19948614
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tegaserod for the treatment of irritable bowel syndrome and chronic constipation.
    Evans BW; Clark WK; Moore DJ; Whorwell PJ
    Cochrane Database Syst Rev; 2007 Oct; (4):CD003960. PubMed ID: 17943807
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of tegaserod in chronic constipation in men.
    Fried M; Johanson JF; Gwee KA; Wagner A; Pecher E; Rueegg P
    Am J Gastroenterol; 2007 Feb; 102(2):362-70. PubMed ID: 17156137
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [A randomized, double-blind, placebo-controlled, multicenter study to assess the efficacy and safety of tegaserod in Chinese patients with constipation-predominant irritable bowel syndrome].
    Tegaserod Clinical Research Group
    Zhonghua Nei Ke Za Zhi; 2003 Feb; 42(2):88-90. PubMed ID: 12783702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.